Befejeződött1. fázis
A Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of Selnoflast in Participants with Moderate to Severe Asthma
Key facts
- Where
- Ahrensburg, Berlin, Frankfurt am Main, Luebeck és Mainz, NémetországSee the 5 sites
- Phase
- 1. fázis
Where in Németország
- Velocity Clinical Research Germany GmbHAhrensburg, NémetországNo longer taking part
- Parexel International GmbHBerlin, NémetországNo longer taking part
- IKF Pneumologie GmbH & Co. KGFrankfurt am Main, NémetországNo longer taking part
- Velocity Clinical Research Germany GmbHLuebeck, NémetországNo longer taking part
- IKF Pneumologie GmbH & Co. KGMainz, NémetországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- F. Hoffmann-La Roche AG
- Trial code
- EU 2023-504304-29-00
- Record updated
- 2025. szeptember 15.